Insider Transactions in Q2 2022 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
406
-1.95%
|
$6,902
$17.75 P/Share
|
|
Jun 17
2022
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,145
-1.76%
|
$19,465
$17.75 P/Share
|
|
Jun 17
2022
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
1,145
-0.39%
|
$19,465
$17.75 P/Share
|
|
Jun 17
2022
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
665
-2.04%
|
$11,305
$17.75 P/Share
|
|
Jun 16
2022
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+8.65%
|
-
|
|
Jun 16
2022
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+32.86%
|
-
|
|
Jun 16
2022
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+32.86%
|
-
|
|
Jun 16
2022
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+24.47%
|
-
|
|
Jun 16
2022
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+29.49%
|
-
|
|
Jun 16
2022
|
Sushil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jun 16
2022
|
Neil Exter Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,200
+15.29%
|
-
|
|
Jun 08
2022
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 08
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
419,901
-7.6%
|
$8,398,020
$20.25 P/Share
|